⚠ FOR RESEARCH USE ONLY • Not for human or animal consumption • Not intended to diagnose, treat, cure, or prevent any disease • Read full disclaimer
£0.00
This product is intended strictly for laboratory research and in-vitro studies.
NOT FOR HUMAN OR ANIMAL CONSUMPTIONS.
Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm you are a qualified researcher or laboratory professional.
✓ CoA Verified
Original price was: £260.00.£230.00Current price is: £230.00.
Product Name: Survodutide
Strength: 10mg
Research Category: Dual GLP-1 / Glucagon Receptor Agonist
Alternative Name: BI 456906
Molecular Formula: C225H348N48O68
Molecular Weight: Approximately 4,835 Da
Peptide Type: Synthetic peptide
Appearance: Typically supplied as a lyophilized peptide powder for research applications.
Research Interest: Metabolic regulation, body-weight regulation, energy expenditure, glucose metabolism, and liver-fat metabolism.
Survodutide (BI 456906) is an investigational synthetic peptide designed as a dual agonist of the glucagon-like peptide-1 (GLP-1) receptor and glucagon receptor. It is being studied for its potential effects on appetite regulation, energy metabolism, body weight, glucose homeostasis, and metabolic liver conditions.
Survodutide combines GLP-1 receptor activity with glucagon receptor activity. GLP-1 receptor activation is associated with appetite and glucose regulation, while glucagon receptor activation may influence energy expenditure and lipid metabolism. This dual-receptor profile is the basis of ongoing research into Survodutide for metabolic and weight-related conditions.
Storage requirements depend on the formulation and supplier specifications. Research material should be stored according to the accompanying certificate of analysis and manufacturer instructions.
Survodutide is an investigational compound and is not approved for general therapeutic use. Information provided here is for scientific and research reference purposes only and is not medical or dosing advice.